Search Within

Mark Kris

  1. "Early Drug Development Service"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (6)
Groups
  1. Department of Medicine (16)
  2. Department of Pathology and Laboratory Medicine (16)
  3. Early Drug Development Service (16)
  4. Solid Tumor Oncology Division (16)
  5. Thoracic Oncology (16)
  6. GSK Faculty (13)

More Groups

People
  1. Alexander Drilon (13)
  2. David Hyman (13)
  3. Maria Arcila (13)
  4. Bob Li (9)
  5. Charles Rudin (9)
  6. Michael Berger (9)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2020 (1)
  4. 2019 (4)
  5. 2018 (3)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Discovery (2)
  3. Clinical Cancer Research (2)
  4. Journal of Thoracic Oncology (2)
  5. Annals of Oncology (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (5)
  3. Elsevier Inc. (2)
  4. Oxford University Press (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II "basket" trial
    Meeting Abstract

    Li, B. T.; Zauderer, M.; Chaft, J.; Drilon, A.; Eng, J.; Sima, C.; Makker, V.; Iyer, G.; Janjigian, Y.; Hyman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay
    Meeting Abstract

    Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save